Moderna’s mRNA vaccine adds to a short IDO pipeline

Moderna is betting its mRNA vaccine take on IDO and checkpoint inhibition will overcome the hurdles that befell Incyte’s small molecule inhibitor by relying on immune killing instead of biochemical inhibition.

The program is one of seven against the metabolic regulator, five of which are in clinical trials, according to BioCentury’s BCIQ database...